Chapter 14 Interactions between the Membrane-Cytoskeleton and CD44 during Lymphocyte Signal Transduction and Cell Adhesion

Current Topics in Membranes and Transport

Volumn 43, Issue C, 1996, Pages 293-312

  Bourguignon, Lilly Y W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1842305589     PISSN: 00702161     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2161(08)60394-9     Document Type: Article

References (87)

1. Arch R., Wirth K., Hofmann M., Ponta H., Matzku S., Herrlich P., and Zoller M. Participation in normal immune responses of a metastasis-inducing splicing variant of CD44. Science 257 (1992) 682-685
2. Belitsos P.C., Hilderth J.E.K., and August J.T. Homotypic cell aggregation induced by anti-CD44(Pgp-1) monoclonal antibodies and related to CD44(Pgp-1) expression. J. Immunol. 144 (1990) 1661-1670
3. Bennet K., Jackson D.G., Simon J.C., Tanczos E., Peach R., Modrell B., Stamenkovic I., Plowman G., and Aruffo A. CD44 isoforms containing exon v3 are responsible for the presentation of heparin binding growth factors. J. Cell Biol. 128 (1995) 687-698
4. Bennett V. Ankyrins: Adapters between diverse plasma membrane proteins and the cytoplasm. J. Biol. Chem. 267 (1992) 8703-8706
5. Bourguignon L.Y.W. Membrane skeleton linker proteins in immune cells. In: Roitt I.M., and Delves P.J. (Eds). "Encyclopedia of Immunology" (1992), Academic Press, New York 1044-1046
6. 2+ release. J. Biol. Chem. 270 (1995) 7257-7260
7. Bourguignon L.Y.W., Walker G., Suchard S., and Balazovich K. A lymphoma plasma membrane-associated protein with ankyrin-like properties. J. Cell Biol. 102 (1986) 2115-2124
8. Bourguignon L.Y.W., Kalomiris E., and Lokeshwar V.B. Acylation of the lymphoma transmembrane glycoprotein, GP85, may be required for GP85-ankyrin interaction. J. Biol. Chem. 266 (1991) 11761-11765
9. Bourguignon L.Y.W., Lokeshwar V.B., He J., Chen X., and Bourguignon G.J. A CD44-like endothelial transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin. Mol. Cell. Biol. 12 (1992) 4464-4471
10. 2+ storage vesicles in mouse T-lymphoma cells. J. Biol. Chem. 268 (1993) 7290-7297
11. Bourguignon L.Y.W., Lokeshwar V.B., Chen X., and Kerrick W.G.L. Hyalu- ronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)- cytoskeleton interaction. J. Immunol. 151 (1993) 6634-6644
12. 2+ release in mouse T-lymphoma cells. J. Biol. Chem. 270 (1995) 17917-17922
13. Bourne H.R., Sanders D.A., and McCormik F. The ATPase superfamily: Conserved structural and molecular mechanism. Nature (London) 349 (1991) 117-127
14. Carter W.G., and Wayner E.A. Characterization of the class III collagen receptor, a phosphorylated transmembrane glycoprotein expressed in nucleated human cells. J. Biol. Chem. 263 (1988) 4193-4201
15. Cooper D.L., and Dougherty G.J. To metastasize or not? Selection of CD44 splice sites. Nature Med. 1 (1995) 635-637
16. Davis J., Lux S.E., and Bennett V. Mapping the ankyrin binding site of human erythrocyte anion exchanger. J. Biol. Chem. 264 (1989) 9665-9672
17. Droll A., Dougherty S.T., Chiu R.K., Dirks J.F., McBride W.H., Cooper D.L., and Dougherty G.J. Adhesive interactions between alternatively spliced CD44 iso-forms. J. Biol. Chem. 270 (1995) 11567-11573
18. Goldstein L.A., Zhou D.F.H., Picker L.J., Minty C.N., Bargatze R.F., Ding J.F., and Butcher E.C. A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56 (1989) 1063-1072
19. Green S.J., Tarone G., and Underhill C.B. Aggregation of macrophages and fibroblasts is inhibited by a monoclonal antibody to the hyaluronate receptor. Exp. Cell Res. 178 (1988) 224-232
20. Gunthert U., Hoffman M., Rudy W., Reher S., Zoller M., Haussmann I., Matzku S., Wenzel A., Ponta H., and Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65 (1991) 13-24
21. Haynes B.F., Telen M.J., Hale L.P., and Denning S.M. CD44-a molecule involved in leukocyte adherence and T-cell activation. Immunol. Today 10 (1989) 423-428
22. He Q., Lesley J., Hyman R., Ishihara K., and Kincade P.W. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J. Cell Biol. 119 (1992) 1711-1719
23. Heider K.H., Hofmann M., Hors E., Berg F.V.D., Ponta H., Herrlich P., and Pal S.T. A human homologue of the rat metastasis associated variant of CD44 is expressed in colorectal carcinoma and adenomatous polyps. J. Cell Biol. 120 (1993) 227-233
24. Herrlich P., Zoller M., Pals S.T., and Ponta H. CD44 splice variants: Metastases meet lymphocytes. Immunol. Today 14 (1993) 395-399
25. Hofmann M., Rudy W., Zoller M., Tolg C., Ponta H., Herrlich P., and Gunthert U. CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cells. Cancer Res. 51 (1991) 5292-5297
26. Horst E., Meijer C.J., Radaszkiewicz T., Ossekoppele G.J., Van Krieken J.H., and Pals S.T. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: Expression of a lymphocyte homing receptor (CD44). LFA (CD11a/t8). and ICAM-1 (CD54). Leukemia 4 (1990) 595-599
27. Hyman R., Lesley J., and Schulte R. Somatic cell mutants distinguish CD44 expression and hyaluronic acid binding. Immunogenetics 33 (1991) 392-395
28. Iida N., and Bourguignon L.Y.W. New CD44 splice variants associated with human breast cancers. J. Cell Physiol. 162 (1995) 127-133
29. Iida N., and Bourguignon L.Y.W. Alteration of cell adhesion and breast tumor cell behavior by CD44 variant isoforms. Proc. Am. Assoc. Cancer Res. 36 (1995) 62
30. Isacke C.M. The role of the cytoplasmic domain in regulating CD44 function. J. Cell Sci. 107 (1994) 2353-2359
31. Isacke C.M., Sauvage C.A., Hyman R., Lesley J., Schulte R., and Trowbridge I.S. Identification and characterization of the human Pgp-1 glycoprotein. Immunogenetics 23 (1986) 326-332
32. Jackson D.G., Bell J.I., Dickinson R., Timans J., Shields J., and Whittle N. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J. Cell Biol. 128 (1995) 673-685
33. Jalkanen S., and Jalkanen M. CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol. 116 (1992) 817-825
34. Jalkanen S., Bargatze R.F., de los Toyos J., and Butcher E.C. Lymphocyte recognition of high endothelium antibodies to distinct epitopes of an 85-95.D glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J. Cell Biol. 105 (1987) 983-990
35. Jalkanen S., Jalkanen M., Bargatze R., Tammi M., and Butcher E.C. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J. Immunol. 141 (1988) 1615-1623
36. Jalkanen S., Joensuu H., Soderstrom K.O., and Klemi P. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J. Clin. Invest. 87 (1991) 1835-1840
37. Kalomiris E.L., and Bourguignon L.Y.W. Mouse T-lymphoma cells contain a transmembrane glycoprotein (GP85) which binds ankyrin. J. Cell Biol. 106 (1988) 319-327
38. Kalomiris E.L., and Bourguignon L.Y.W. Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in GP85-ankyrin binding. J. Biol. Chem. 264 (1989) 8113-8119
39. Katoh S., Zheng Z., Oritani K., Shimozato T., and Kincade P.W. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 182 (1995) 419-429
40. Kordeli E., and Bennett V. Distinct ankyrin isoforms at neuron cell bodies and nodes of Ranvier resolved using erythrocyte ankyrin-deficient mice. J. Cell Biol. 114 (1991) 1243-1259
41. Kordeli E., Lambert S., and Bennett V. AnkyrinG, a new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier. J. Biol. Chem. 270 (1995) 2352-2359
42. Laurent T.C., and Fraser J.R. Hyaluronan. FASEB J. 6 (1992) 2397-2404
43. Lesley J., and Trowbridge I.S. Genetic characterization of a murine polymorphic cell surface glycoprotein. Immunogenetics 15 (1982) 313-320
44. Lesley J., Hyman R., and Schulte R. Evidence that the Pgp-1 glycoprotein is expressed on thymus-homing progenitor cells of the thymus. Cell. Immunol. 91 (1985) 397-403
45. Lesley J., Trotter J., and Hyman R. The Pgp-1 antigen is expressed on early fetal thymocytes. Immunogenetics 22 (1985) 149-157
46. Lesley J.R., Schulte R., and Hyman R. Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp. Cell Res. 187 (1990) 224-233
47. Lesley J., He Q., Miyake K., Hamann A., Hyman R., and Kincade P. Requirement for hyaluronic acid binding by CD44: A role for the cytoplasmic domain and activation by antibody. J. Exp. Med. 175 (1992) 257-266
48. Lesley J., English N., Perschl A., Gregoroff J., and Hyamn R. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med. 182 (1995) 431-437
49. Letarte M., Iturbe S., and Quackenbush E.J. A glycoprotein of molecular weight 85, 000 on human cells of B-lineage: Detection with a family of monoclonal antibodies. Mol. Immunol. 22 (1985) 113-124
50. Liao H.X., Levesque M.C., Patton K., Bergamo B., Jones D., Moody A., Telen M.J., and Haynes B.F. Regulation of human CD44H and CD44E isoform binding to hyaluronan by PMA and anti-CD44 monoclonal and polyclonal antibodies. J. Immunol. 151 Suppl. 11 (1993) 6490
51. Liao H.X., Lee D.M., Levesque M.C., and Haynes B.F. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding. J. Immunol. 155 (1995) 3938-3945
52. Lokeshwar V.B., and Bourguignon L.Y.W. Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1.CD44) and its biosynthesis precursors during T-lymphoma membrane biosynthesis. J. Biol. Chem. 266 (1991) 17983-17989
53. Lokeshwar V.B., and Bourguignon L.Y.W. The lymphoma transmembrane glycopro- tein GP85 (CD44) is a novel guanine nucleotide-binding protein which regulates GP85 (CD44)-ankyrin interaction. J. Biol. Chem. 267 (1992) 22073-22078
54. Lokeshwar V.B., Fregien N., and Bourguignon L.Y.W. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol. 126 (1994) 1099-1109
55. Matsumura Y., and Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340 (1992) 1053-1058
56. Miyake K., and Kincade P.W. A new cell adhesion mechanism involving hyaluronate and CD44. Curr. Top. Microbiol. Immunol. 166 (1990) 87-90
57. Miyake K., Medina K.L., Hayashi S.I., Ono S., Hamaoka T., and Kincade P.W. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow culture. J. Exp. Med. 171 (1990) 477-488
58. Miyake K., Underhill C.B., Lesley J., and Kincade P.W. Hyaluronate can function as a cell adhesion molecule and CD44 participate in hyaluronate recognition. J. Exp. Med. 172 (1990) 69-75
59. +-ATPase in Madin-Darby canine kidney cells and in intact renal tubule cells. J. Cell Biol. 108 (1989) 455-465
60. +-ATPase and implications for the organizations of membrane domains in polarized cells. Nature (London) 328 (1987) 533-536
61. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258 (1992) 607-614
62. Peach R.J., Hollenbaugh D., Stamenkovic I., and Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122 (1993) 257-264
63. Perschl A., Lesley J., English N., Trowbridge I., and Hyman R. Role of CD44 cytoplasmic domain in hyaluronan binding. Eur. J. Immunol. 25 (1995) 495-501
64. Pure E., Camp R.L., Peritt D., Panettieri Jr. P.A., Lazaar A.L., and Nayak S. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med. 181 (1995) 55-62
65. Quackenbush E.J., Vera S., Greaves A., and Letarte M. Confirmation by peptide sequence and co-expression on various cell types of the identity of CD44 and p85 glycoprotein. Mol. Immunol. 27 (1990) 947-955
66. Ristamaki R., Joensuu H., Soderstrom K.O., and Jalkanen S. CD44v6 expression in non-Hodgkin's lymphoma: An association with low histological grade and poor prognosis. J. Pathol. 176 (1995) 259-267
67. Rooney P., Kumar S., and Wang M. The role of hyaluronan in tumor neovascularization. Int. J. Cancer 60 (1995) 632-636
68. Schmidt M.F.G. Fatty acylation of proteins. Biochim. Biophys. Acta 988 (1989) 411-426
69. Screaton G.R., Bell M.V., Jackson D.G., Cornelis F.B., Gerth U., and Bell J.I. Genomic structure of DNA coding the lymphocyte homing receptor CD44 reveals 12 alternatively spliced exons. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 12160-12164
70. +- ATPase α2 gene and identification of the intragenic restriction fragment length polymorphism. J. Biol. Chem. 264 (1989) 17532-17543
71. Smith P.R., Saccomani G., Joe E.H., Angelides K.J., and Benos D.J. Amiloride sensitive sodium channel is linked to the cytoskeleton in renal epithelial cells. Proc. Narl. Acad. Sci. U.S.A. 88 (1991) 6971-6975
72. Sorimachi N.T., Sorimachi H., Tobita Y., Kitamura F., Yagita H., Suzuki K., and Miyasaka M. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. J. Biol. Chem. 270 (1995) 7437-7444
73. Stamenkovic I., Amiot M., Pesando J.M., and Seed B. The hemopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronon-bearing cells. EMBO. J. 10 (1991) 343-347
74. Stamper Jr. H.B., and Woodruff J.J. Lymphocyte homing into lymph nodes: In vitro demonstration of the selective affinity of recirculating lymphocytes for high endothelial venules. J. Exp. Med. 144 (1976) 828-833
75. Tolg C., Hofmann M., Herrlich P., and Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 21 (1993) 1225-1229
76. Trowbridge I.S., Lesley J., Sculte R., Hyman R., and Trotte J. Biochemical characterization and cellular distribution of a polymorphic murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics 15 (1982) 299-312
77. Tsukita T., Oishi K., Sato N., Sagara J., Kawai A., and Tsukita S. ERM family members as molecular linkers between CD44 and actin-based cytoskeleton. J. Cell Biol. 126 (1994) 391-421
78. Turley E.A., Austen L., Vandeligt K., and Clary C. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J. Cell Biol. 112 (1991) 1041-1047
79. Uff C.R., Neame S.J., and Isacke C.M. Hyaluronic binding by CD44 is regulated by a phosphorylation-independent mechanism. Eur. J. Immunol. 25 (1995) 1883-1887
80. Underhill C.B. Interaction of hyaluronate with the surface of simian virus 40-trans-formed 2T2 cells: Aggregation and binding studies. J. Cell Sci. 56 (1982) 177-189
81. Underhill C.B., Thurn A.L., and Lacy B.E. Characterization and identification of the hyaluronate-binding site from membranes of SV-3T3 cells. J. Biol. Chem. 260 (1985) 8128-8133
82. Underhill C.B., Green S.J., Comoglio P.M., and Tarone G. The hyaluronate receptor is identical to a glycoprotein of 85, 000 Mr. (gp85) as shown by a monoclonal antibody that interferes with binding activity. J. Biol. Chem. 262 (1987) 13142-13146
83. Welsh C.F., Zhu D., and Bourguignon L.Y.W. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells. J. Cell Physiol. 164 (1995) 605-612
84. West D.C., and Kumar S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp. Cell Res. 183 (1989) 179-196
85. Yamamo-Hino M., Sugiyama T., Hikichi K., Mattei M.G., Hasegawa K., Sekine S., Sakurada K., Miyawaki A., Furuichi T., Hasegawa M., and Mikoshiba K. Cloning and characterization of human type 2 and type 3 inositol 1,4,5-triphosphate receptors. Receptors Channels 2 (1994) 9-22
86. Yang B., Yang B.L., Savani R.C., and Turley E.A. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J. 13 (1994) 286-296
87. Zhou D.F.H., Ding J.F., Picker L.J., Bargatze R.F., Butcher E.C., and Goeddel D.V. Molecular cloning and expression of Pgp-1: the mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor. J. Immunol. 143 (1989) 3390-3395